519. Risk Factor Analysis for Hospital Admission Following Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Monoclonal Antibody Treatment
Publication
, Journal Article
Abusalem, L; Wood, C; Crescencio, JCR; Dare, RK
Published in: Open Forum Infectious Diseases
December 4, 2021
Duke Scholars
Published In
Open Forum Infectious Diseases
DOI
EISSN
2328-8957
Publication Date
December 4, 2021
Volume
8
Issue
Supplement_1
Start / End Page
S361 / S361
Publisher
Oxford University Press (OUP)
Citation
APA
Chicago
ICMJE
MLA
NLM
Abusalem, L., Wood, C., Crescencio, J. C. R., & Dare, R. K. (2021). 519. Risk Factor Analysis for Hospital Admission Following Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Monoclonal Antibody Treatment. Open Forum Infectious Diseases, 8(Supplement_1), S361–S361. https://doi.org/10.1093/ofid/ofab466.718
Abusalem, Lana, Cole Wood, Juan Carlos Rico Crescencio, and Ryan K. Dare. “519. Risk Factor Analysis for Hospital Admission Following Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Monoclonal Antibody Treatment.” Open Forum Infectious Diseases 8, no. Supplement_1 (December 4, 2021): S361–S361. https://doi.org/10.1093/ofid/ofab466.718.
Abusalem L, Wood C, Crescencio JCR, Dare RK. 519. Risk Factor Analysis for Hospital Admission Following Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Monoclonal Antibody Treatment. Open Forum Infectious Diseases. 2021 Dec 4;8(Supplement_1):S361–S361.
Abusalem, Lana, et al. “519. Risk Factor Analysis for Hospital Admission Following Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Monoclonal Antibody Treatment.” Open Forum Infectious Diseases, vol. 8, no. Supplement_1, Oxford University Press (OUP), Dec. 2021, pp. S361–S361. Crossref, doi:10.1093/ofid/ofab466.718.
Abusalem L, Wood C, Crescencio JCR, Dare RK. 519. Risk Factor Analysis for Hospital Admission Following Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Monoclonal Antibody Treatment. Open Forum Infectious Diseases. Oxford University Press (OUP); 2021 Dec 4;8(Supplement_1):S361–S361.
Published In
Open Forum Infectious Diseases
DOI
EISSN
2328-8957
Publication Date
December 4, 2021
Volume
8
Issue
Supplement_1
Start / End Page
S361 / S361
Publisher
Oxford University Press (OUP)